|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynaecology, Maternité Port-Royal Hospital, Cochin APHP University René Descartes, Paris, France.
Address reprint requests to: Gilles Kayem, MD, Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal de Créteil, Créteil, France; e-mail: gilles.kayem{at}chicreteil.fr.
OBJECTIVE: To compare the impact of conservative and extirpative strategies for placenta accreta on maternal morbidity and mortality.
METHODS: We retrospectively reviewed the medical records of all patients diagnosed with placenta accreta admitted to our tertiary center from January 1993 through December 2002. Two consecutive periods, A and B, were compared. During period A (January 1993 to June 1997), our written protocol called for the systematic manual removal of the placenta, to leave the uterine cavity empty. In period B (July 1997 to December 2002), we changed our policy by leaving the placenta in situ. The following outcomes over the 2 periods were compared: need for blood transfusion, hysterectomy, intensive care admission, duration of stay in intensive care, and postpartum endometritis.
RESULTS: Thirty-three cases of placenta accreta were observed among 31,921 deliveries (1.03/1,000). During period B, there was a reduction in the hysterectomy rate (from 11 [84.6%] to 3 [15%]; P < .001), the mean number of red blood cells transfused (3,230 ± 2,170 mL versus 1,560 ± 1,646 mL; P < .01), and disseminated intravascular coagulation (5 [38.5%] versus 1 [5.0%]; P = .02), compared with period A. There were 3 cases of sepsis in period B and none in period A (P = .26). At least 2 women with conservative management subsequently had successful pregnancies.
CONCLUSION: Leaving the placenta accreta in situ appears to be a safe alternative to removing the placenta.
LEVEL OF EVIDENCE: II-3
This article has been cited by other articles:
![]() |
O. L. Most, T. Singer, I. Buterman, A. Monteagudo, and I. E. Timor-Tritsch Postpartum Management of Placenta Previa Accreta Left In Situ: Role of 3-Dimensional Angiography J. Ultrasound Med., September 1, 2008; 27(9): 1375 - 1380. [Full Text] [PDF] |
||||
![]() |
A. M. E. Hays, K. C. Worley, and S. R. Roberts Conservative Management of Placenta Percreta: Experiences in Two Cases Obstet. Gynecol., August 1, 2008; 112(2): 425 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Tan, K. H. Tay, K. Sheah, K. Kwek, K. Wong, H. K. Tan, and B. S. Tan Perioperative Endovascular Internal Iliac Artery Occlusion Balloon Placement in Management of Placenta Accreta Am. J. Roentgenol., November 1, 2007; 189(5): 1158 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oyelese and J. C. Smulian Placenta previa, placenta accreta, and vasa previa. Obstet. Gynecol., April 1, 2006; 107(4): 927 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fiori, N. Berkane, and S. Uzan Conservative Versus Extirpative Management in Cases of Placenta Accreta Obstet. Gynecol., January 1, 2005; 105(1): 219 - 220. [Full Text] [PDF] |
||||
![]() |
K. Nishijima, K.-i. Shukunami, H. Tsukahara, and F. Kotsuji Conservative Versus Extirpative Management in Cases of Placenta Accreta Obstet. Gynecol., January 1, 2005; 105(1): 220 - 220. [Full Text] [PDF] |
||||
![]() |
G. Kayem, C. Davy, F. Goffinet, C. Thomas, D. Clement, and D. Cabrol Conservative Versus Extirpative Management in Cases of Placenta Accreta Obstet. Gynecol., January 1, 2005; 105(1): 220 - 221. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |